➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Medtronic
Dow
Moodys
Harvard Business School

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 6,565,897

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,565,897
Title: Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
Abstract:A substantially sterile extract of Nerium species is described, together with a method for production thereof. A pharmaceutical composition comprising the extract is also described, together with a method for production thereof. The pharmaceutical composition is useful for the treatment of cell-proliferative and immune deficient diseases in mammals, including cancer and AIDS, respectively.
Inventor(s): Selvaraj; Ulagaraj (San Antonio, TX), Singh; Chandra U. (San Antonio, TX), Ozel; Huseyin Z. (Istanbul, TK)
Assignee: Ozelle Pharmaceuticals, Inc. (San Antonio, TX)
Application Number:09/401,494
Patent Claims:see list of patent claims

Details for Patent 6,565,897

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Ozelle Pharmaceuticals, Inc. (San Antonio, TX) 2018-09-24 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Ozelle Pharmaceuticals, Inc. (San Antonio, TX) 2018-09-24 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Baxter
Merck
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.